301207 華蘭疫苗
按盤價 
19.740 +0.060 (+0.305%)
19.740 +0.060 (+0.305%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.327 | 14.626 | 12.514 | 24.863 | 53.628 |
| 總資產報酬率 ROA (%) | 3.420 | 11.412 | 8.960 | 15.199 | 33.991 |
| 投入資產回報率 ROIC (%) | 4.112 | 13.868 | 11.346 | 21.417 | 49.637 | 邊際利潤分析 |
| 銷售毛利率 (%) | 81.054 | 88.089 | 88.089 | 87.935 | 89.369 |
| 營業利潤率 (%) | 31.949 | 41.904 | 32.462 | 38.637 | 44.268 |
| 息稅前利潤/營業總收入 (%) | 31.152 | 41.564 | 31.989 | 39.018 | 44.293 |
| 淨利潤/營業總收入 (%) | 27.927 | 35.677 | 28.463 | 33.936 | 38.120 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 65.262 | 99.640 | 117.066 | 113.125 | 105.049 |
| 價值變動淨收益/利潤總額(%) | 24.466 | 10.942 | 12.290 | 5.385 | 0.923 |
| 營業外收支淨額/利潤總額(%) | 0.010 | -0.315 | -0.535 | -0.174 | -0.003 | 償債能力分析 |
| 流動比率 (X) | 3.081 | 3.101 | 2.728 | 1.513 | 1.695 |
| 速動比率 (X) | 2.919 | 2.998 | 2.619 | 1.448 | 1.664 |
| 資產負債率 (%) | 20.250 | 21.666 | 22.316 | 37.921 | 0.400 |
| 帶息債務/全部投入資本 (%) | 4.446 | 4.124 | 4.853 | 14.595 | 10.851 |
| 股東權益/帶息債務 (%) | 2,133.956 | 2,307.421 | 1,945.534 | 576.286 | 819.218 |
| 股東權益/負債合計 (%) | 393.816 | 361.563 | 348.118 | 163.703 | 149.714 |
| 利息保障倍數 (X) | -38.931 | -199.512 | -106.640 | 87.031 | 1,658.842 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 521.469 | 282.792 | 318.997 | 292.040 | 164.638 |
| 存貨周轉天數 (天) | 310.596 | 213.562 | 227.277 | 124.487 | 70.526 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 13:09 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
